Bright Minds Biosciences DRUG
NASDAQ DRUG
$49.21 -0.61 (-1.22%)
At close: Oct 1, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) EV to CFO (2021 - 2025)

Updated

Bright Minds Biosciences' (DRUG) EV to CFO stood at 27.79 in fiscal Q3 2025 (quarter ended Jun 30, 2025), down 95.3% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) EV to CFO (2021 - 2025) Analysis & Trends

On a TTM basis, Bright Minds Biosciences' EV to CFO came in at -1.17 as of Jun 30, 2025; for FY2022 (ended Sep 30, 2022), it came in at 0.57, down 93.2% from FY2021.

  • Across earlier fiscal years, EV to CFO came in at 8.37 in FY2021.
  • The fiscal Q3 2025 figure is the lowest quarterly EV to CFO since fiscal Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bright Minds Biosciences 380.42 Mn 380.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 27.79
Mar 31, 2025 588.51
Jun 30, 2023 0.17
Mar 31, 2023 -0.25
Dec 31, 2022 0.10
Sep 30, 2022 0.59
Jun 30, 2022 0.04
Mar 31, 2022 0.41
Dec 31, 2021 1.76
Sep 30, 2021 8.27
Jun 30, 2021 -0.31
Mar 31, 2021 11.64
API Access

Bright Minds Biosciences EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=DRUG&period=max&api_key=YOUR_API_KEY